📰 Autonomous Diagnostics News
Autonomous Diagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Autonomous Diagnostics. Real-time updates on events, politics, business and more.
July 29, 2023
The Pentagon's research agency dates back to 1958, and was created in response to a surprise from the USSR. Here's what DARPA does.
July 29, 2023
The famous DOD research arm has been working on tech breakthroughs since 1958. Here's how it got started—and what it does now.
November 7, 2022
The mRNA vaccines were not a product of Operation Warp Speed and developed in just a few months -- rather, DARPA has been working on them with companies such as Moderna since 2011.
January 6, 2022
SARS-CoV-2 adds impetus to the race for broad-spectrum countermeasures against future global infectious scourges
June 1, 2021
October 2, 2013 at 9:00 AM EDT Research to focus on antibody production for immune defense CAMBRIDGE, Mass., October 2, 2013—Moderna Therapeutics, the company pioneering messenger RNA therapeutics™, a revolutionary new treatment modality to enable the in vivo production of therapeutic proteins, announced today that the Defense Advanced Research Projects Agency (DARPA) has awarded the company up to $25 million to research and develop its messenger RNA therapeutics™ platform as a rapid ...
May 6, 2021
Is DARPA implantable microchip to detect COVID-19 the mark of the beast? (Photo credit: Shutterstock.com / Gorodenkoff) The Defense Advanced Research Projects Agency, commonly referred to as DARPA, was established during the Cold War more than 60 years ago. For 60 years, DARPA has maintained and advanced the mission of making “pivotal investments in breakthrough technologies for national security.” Many are familiar with their human and animal-like robots, but recently, they have ta...
December 29, 2020
TMCnet News Heru, Inc., A 3 Seasons Capital, LLC Portfolio Medical Technology Company, Receives Class 1 Listing With the FDA for Developing a Next-Generation, Artificial Intelligence (AI)-Driven Platform for Vision Diagnostics and Augmentation [December 28, 2020] Heru, Inc., A 3 Seasons Capital, LLC Portfolio Medical Technology Company, Receives Class 1 Listing With the FDA for Developing a Next-Generation, Artificial Intelligence (AI)-Driven Platform for Vision Diagnostics and Augmentation MIA...